London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami 15-04-2024, 19:00

Local Town Hall Meetings to Stop Ford’s Plans to Privatize 8-02-2023, 04:54

onsemi Announces Proposed Private Offering of $1.3 Billion of Convertible Senior Notes 6-05-2026, 18:19